Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

120.28 -1.22 (-1.00%)
Streaming Delayed Price Updated: 9:34 AM EDT, Mar 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
36 37 Next >
News headline image
3 Profitable Stocks with Open Questions
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi... 
Via StockStory
News headline image
Life Sciences Tools & Services Stocks Q4 In Review: 10x Genomics (NASDAQ:TXG) Vs Peers
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including 10x Genomics (NASDAQ:TXG) and its ... 
Via StockStory
Topics Artificial Intelligence
News headline image
Life Sciences Tools & Services Stocks Q4 Recap: Benchmarking PacBio (NASDAQ:PACB)
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at PacBio (NASDAQ:PACB) and its ... 
Via StockStory
Topics Artificial Intelligence
News headline image
The "Flight to Quality": Thermo Fisher’s Q4 Beat and Dividend Hike Cement Defensive Leadership for 2026
WALTHAM, MA — In a market defined by shifting geopolitical alliances and a renewed "flight to quality," Thermo Fisher Scientific (NYSE:TMO) has once again asserted its dominance as the bedrock of the... 
Via MarketMinute
Topics Earnings Economy World Trade
Illumina Inc (NASDAQ:ILMN) Stock Falls Despite Q4 Earnings Beat on Cautious 2026 Outlook ↗
Via Chartmill
Topics Earnings
News headline image
What a $75 Million Exit From MDU Might Signal Amid a 24% One-Year Rally ↗
MDU Resources Group supplies regulated utilities and construction services across the U.S., with consistent revenue and a stable dividend. 
Via The Motley Fool
Topics Energy
News headline image
1 Healthcare Stock Worth Your Attention and 2 Facing Challenges
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only... 
Via StockStory
Topics Stocks
News headline image
5 Insightful Analyst Questions From Illumina’s Q4 Earnings Call
Illumina’s fourth quarter was marked by strong performance in its clinical consumables business, with management citing 20% year-over-year growth outside China as a key driver. CEO Jacob Thaysen... 
Via StockStory
Topics Earnings
News headline image
10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect
Biotech company 10x Genomics (NASDAQ:TXG) will be reporting earnings this Thursday after market hours. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
PacBio Earnings: What To Look For From PACB
Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be announcing earnings results this Thursday after market hours. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
Could Nvidia Be the Best Way to Play the AI Boom in 2026? ↗
Nvidia was propelled to its current highs by the development of AI, but is it still one of the best ways to play it? 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Harvard’s PopEVE AI Cracks the Code of Rare Diseases: Ending the ‘Diagnostic Odyssey’ for Millions
In a landmark achievement for computational biology, researchers from Harvard Medical School and the Centre for Genomic Regulation (CRG) have unveiled PopEVE, a groundbreaking artificial intelligence... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
The Great AI Land Grab: Why Tech Giants are Paying Billions for Talent While Deal Volumes Sink
As of February 6, 2026, the technology sector is witnessing a paradoxical shift in the mergers and acquisitions (M&A) landscape. While the sheer number of transactions has hit an eight-year plateau,... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Molina Healthcare, Coty, Illumina, Amazon And Other Big Stocks Moving Lower In Friday&#39;s Pre-Market Session ↗
 
Via Benzinga
News headline image
ILMN Q4 Deep Dive: Clinical Consumables Growth, Multiomics Expansion, and Margin Momentum
Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5% year on year to $1.16 billion. The company’s full-year revenue guidance of $4.55 billion... 
Via StockStory
News headline image
Illumina (ILMN) Q4 2025 Earnings Call Transcript ↗
Illumina (ILMN) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Illumina (NASDAQ:ILMN) Reports Bullish Q4 CY2025
Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5% year on year to $1.16 billion. The company’s full-year revenue guidance of $4.55 billion... 
Via StockStory
News headline image
SBIR Eligibility Requirements: Small Business Qualification Guide Released
Via Press Release Distribution Service
Topics Intellectual Property
News headline image
Cold Chain, High Stakes: A Deep Dive into Azenta’s (AZTA) Life Sciences Transformation
Date: February 5, 2026 Introduction In the high-stakes world of life sciences, the "cold chain" is the invisible backbone of modern medicine. From the development of mRNA vaccines to the emerging... 
Via Finterra
Topics Artificial Intelligence Earnings Economy
News headline image
Illumina (ILMN) Reports Q4: Everything You Need To Know Ahead Of Earnings
Genomics company Illumina (NASDAQ:ILMN) will be reporting results this Thursday after market close. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
News headline image
The Analyst Verdict: Illumina In The Eyes Of 15 Experts ↗
 
Via Benzinga
News headline image
The Silicon Ceiling Shatters: S&P 500’s Historic Ascent Past 5,300 and the AI Anchor
In a definitive display of market resilience, the S&P 500 (CME:GSPC) achieved a landmark milestone in May 2024, crossing the 5,300 threshold for the first time in history. This surge, culminating in a... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Here&#39;s How Much You Would Have Made Owning Illumina Stock In The Last 20 Years ↗
 
Via Benzinga
News headline image
Life Sciences Tools & Services Stocks Q3 Teardown: Illumina (NASDAQ:ILMN) Vs The Rest
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers. 
Via StockStory
Topics Artificial Intelligence
News headline image
Illumina Gets Medicare Boost for Cancer Test, Shares Climb ↗
Illumina shares rose after Medicare approved reimbursement for its FDA-approved cancer test, a move expected to drive growth. 
Via Benzinga
News headline image
3 Cash-Producing Stocks with Open Questions
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Inflated Stocks We Approach with Caution
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial... 
Via StockStory
News headline image
GRAIL Surges as Canaccord Genuity Sets Ambitious $105 Price Target Following Robust 2025 Growth
In a resounding vote of confidence for the future of multi-cancer early detection (MCED), Canaccord Genuity reiterated its "Buy" rating for GRAIL (Nasdaq: GRAL) on Tuesday, January 13, 2026, setting an... 
Via MarketMinute
News headline image
Adaptive Biotechnologies Surges as Preliminary 2025 Results Signal a Turning Point in MRD Commercialization
Shares of Adaptive Biotechnologies (NASDAQ: ADPT) soared on Tuesday, January 13, 2026, after the life sciences company announced preliminary fourth-quarter and full-year 2025 financial results that... 
Via MarketMinute
News headline image
From Silicon to Syringes: Nvidia’s AI Dominance Solidified Through Landmark Eli Lilly Alliance
In a move that signals the definitive convergence of high-performance computing and biotechnology, NVIDIA Corporation (NASDAQ: NVDA) and Eli Lilly and Company (NYSE: LLY) announced a massive $1 billion... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
36 37 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.